Pharmacological Characteristics and Efficacy of a Novel Anti-Angiogenic Antibody FD006 in Corneal Neovascularization

BMC Biotechnology - United Kingdom
doi 10.1186/1472-6750-14-17
Full Text
Abstract

Available in full text

Categories
Biotechnology
Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Inhibition of Experimental Choroidal Neovascularization by a Novel Peptide Derived From Calreticulin Anti-Angiogenic Domain

2018English

Anti-Angiogenic and Anti-Inflammatory Effects of SERPINA3K on Corneal Injury

PLoS ONE
Multidisciplinary
2011English

Novel Aspects of Corneal Angiogenic and Lymphangiogenic Privilege

Progress in Retinal and Eye Research
OphthalmologySensory Systems
2010English

The Anti-Angiogenic Effect of Chlorogenic Acid on Choroidal Neovascularization

Korean journal of ophthalmology : KJO
Medicine
2010English

Optical Coherence Tomography Angiography of Time Course of Choroidal Neovascularization in Response to Anti-Angiogenic Treatment

Retina
MedicineOphthalmology
2015English

Characterization of a Novel Polyclonal Anti-Hypusine Antibody

SpringerPlus
Multidisciplinary
2013English

Therapeutic Approaches for Corneal Neovascularization

Eye and Vision
2017English

Anti-Angiogenic Activities of Novel Isocoumarins, AGI-7 and Sescandelin.

Journal of Antibiotics
Drug DiscoveryPharmacology
2001English

Comparison of the Effects of Subconjunctival and Topical Anti-Vegf Therapy (Bevacizumab) on Experimental Corneal Neovascularization

Arquivos Brasileiros de Oftalmologia
MedicineOphthalmology
2014English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy